Get Live Data

We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Int.biotech. Share Price
  4. Int.biotech. Share Regulatory News
  5. Compliance with Market Abuse Regulation

Pin to quick picksInt.biotech. Regulatory News (IBT)

Int.biotech. Information

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 616.00
Bid: 612.00
Ask: 620.00
Change: 0.00 (0.00%)
Spread: 8.00 (1.307%)
Open: 616.00
High: 0.00
Low: 0.00
Prev. Close: 616.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Compliance with Market Abuse Regulation

30 Sep 2020 09:52

RNS Number : 5898A
Intl. Biotechnology Trust PLC
30 September 2020
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

 

Compliance with the Market Abuse Regulation (MAR)

 

The Company announces that it is satisfied that all inside information which the Directors and the Company may have in the period leading up to the announcement of the Annual Financial Report for the year ended 31 August 2020 has been notified to a Regulated Information Service (RIS). The Company is therefore not prohibited from purchasing its own securities or re-selling treasury shares during the closed period (as defined by MAR) which ends on the date of the announcement of the Annual Financial Report.

 

If, in the period leading up to the announcement of the Annual Financial Report, the Directors or the Company come into possession of any inside information, this will be notified to a RIS before any such transactions are undertaken.

 

The closed period to which this notification relates is in respect of the year ended 31 August 2020.

 

 

Susan Gledhill

For and on behalf of

BNP Paribas Secretarial Services Limited

Company Secretary

 

Tel: 020 7410 5971

 

 

30 SEPTEMBER 2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CMCEAPNEDSFEEEA
67891011121314
Date   Source Headline
21st Feb 20237:00 amRNSPortfolio Update
13th Feb 20237:00 amRNSInvestment Management Update
7th Feb 20239:00 amRNSDirector Declaration
2nd Feb 20237:00 amRNSPortfolio Update
23rd Jan 20235:22 pmRNSAppointment of Non-executive Director
23rd Jan 20237:00 amRNSPortfolio Update
3rd Jan 20237:00 amRNSBlock listing Interim Review
19th Dec 20229:00 amRNSPortfolio Update
14th Dec 20227:00 amRNSPortfolio Update
12th Dec 20222:23 pmRNSPortfolio Update
8th Dec 20227:47 amEQSHardman & Co Research on International Biotechnology Trust (IBT): Low FDA activity may drive further M&A
6th Dec 20224:24 pmRNSDividend Declaration
6th Dec 20224:18 pmRNSResult of AGM
1st Dec 20222:38 pmRNSTotal Voting Rights
17th Nov 20228:00 amRNSPortfolio Update
9th Nov 20224:48 pmRNSTransaction in Own Shares
8th Nov 20224:41 pmRNSTransaction in Own Shares
7th Nov 20225:20 pmRNSTransaction in Own Shares
4th Nov 20224:40 pmRNSTransaction in Own Shares
3rd Nov 20224:57 pmRNSTransaction in Own Shares
1st Nov 20225:22 pmRNSTransaction in Own Shares
1st Nov 202211:26 amRNSTotal Voting Rights
1st Nov 20227:00 amRNSAnnual Financial Report
31st Oct 20225:20 pmRNSTransaction in Own Shares
27th Oct 20225:33 pmRNSTransaction in Own Shares
26th Oct 20224:39 pmRNSTransaction in Own Shares
25th Oct 20228:00 amRNSPortfolio Update
24th Oct 20225:12 pmRNSTransaction in Own Shares
18th Oct 20225:36 pmRNSTransaction in Own Shares
17th Oct 20221:16 pmRNSTransaction in Own Shares
13th Oct 20225:55 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSKepler Trust Intelligence: New Research
3rd Oct 202212:07 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSCompliance with the Market Abuse Regulation
20th Sep 20225:22 pmRNSTransaction in Own Shares
20th Sep 20228:00 amRNSPortfolio Update
25th Aug 20228:30 amRNSPortfolio Update
1st Aug 202211:12 amRNSTotal Voting Rights
22nd Jul 20223:29 pmRNSDividend Declaration
20th Jul 20229:00 amRNSPortfolio Update
11th Jul 20221:26 pmRNSReplacement: Transaction in Own Shares
7th Jul 20225:45 pmRNSTransaction in Own Shares
6th Jul 20225:16 pmRNSTransaction in Own Shares
1st Jul 20225:40 pmRNSTransaction in Own Shares
1st Jul 20222:37 pmRNSBlock listing Interim Review
30th Jun 20227:15 amEQSHardman & Co Research: International Biotechnology Trust (IBT) - M&A activity on the rise
21st Jun 202210:30 amRNSPortfolio Update
1st Jun 202211:53 amPRNNet Asset Value(s)
1st Jun 202210:14 amRNSTotal Voting Rights
31st May 202210:53 amPRNNet Asset Value(s)
67891011121314

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.